Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pethidine versus doxapram for post-anesthesia shivering
IRCT20140109016151N9Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of pethidine and doxapram in postanesthetic shivering (PAS) (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Shivering after surgery and Hypoxia. Started Aug 2020; status: completed.
02
Drugs
pethidinedoxapram
03
Conditions
postanesthetic shivering (PAS)
Beyond the preview
Go deeper on IRCT20140109016151N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140109016151N9.